|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.16 CAD | 0.00% |
|
-20.00% | +60.00% |
| Apr. 18 | Entheon Biomedical Corp. announced that it has received CAD 0.1475 million in funding | CI |
| Apr. 11 | Entheon Biomedical Corp. announced that it expects to receive CAD 0.1475 million in funding | CI |
Entheon Biomedical Corp. filed its Annual on Mar 23, 2023 for the period ending Nov 30, 2022. In this report its auditor, Manning Elliott, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
| 1st Jan change | Capi. | |
|---|---|---|
| +60.00% | 1.04M | |
| +1.77% | 42.75B | |
| +47.70% | 41.61B | |
| +12.24% | 41.34B | |
| -8.83% | 26.59B | |
| +7.44% | 25.49B | |
| -23.01% | 18.12B | |
| +30.56% | 12.24B | |
| -1.82% | 11.76B | |
| +8.35% | 11B |
ENTHEON BIOMEDICAL CORP. 
